Ionis Pharmaceuticals | IONS - Vermögenswerte





Vermögenswerte Veränderung Datum
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Arrowhead Research USD 2.27B 664.08M 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
BioCryst Pharmaceuticals USD 465.05M 49.11M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Celltrion KRW 759.44B 20.32T 2025-12
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Esperion Therapeutics USD 462.53M 3.36M 2026-03
Exelixis USD 2.59B 250.83M 2026-03
Halozyme Therapeutics USD 2.67B 147.4M 2026-03
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 11.49B 850M 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Neurocrine Biosciences USD 4.91B 274.7M 2026-03
Novartis USD 118.53B 7.58B 2026-03
Omeros USD 200.57M 34.59M 2025-06
OPKO Health USD 1.93B 63.57M 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pfizer USD 207.62B 542M 2026-03
Pharma Mar EUR 385.26M 9.82M 2026-03
PTC Therapeutics USD 2.87B 29.66M 2026-03
Qiagen NV USD 6.3B 257.54M 2025-12
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tilray USD 2.1B 15.95M 2025-09
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03